An international report on bacterial communities in esophageal squamous cell carcinoma.

Saved in:
Bibliographic Details
Title: An international report on bacterial communities in esophageal squamous cell carcinoma.
Authors: Nomburg J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Harvard Program in Virology, Harvard Medical School, Boston, Massachusetts, USA., Bullman S; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Nasrollahzadeh D; Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.; International Agency for Research on Cancer (IARC), Genomic Epidemiology Branch, Lyon, France., Collisson EA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California, USA.; Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, California, USA., Abedi-Ardekani B; International Agency for Research on Cancer (IARC), Genomic Epidemiology Branch, Lyon, France., Akoko LO; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Atkins JR; International Agency for Research on Cancer (IARC), Genomic Epidemiology Branch, Lyon, France., Buckle GC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California, USA.; Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, California, USA., Gopal S; University of North Carolina (UNC), Chapel Hill, North Carolina, USA., Hu N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Kaimila B; UNC Project, Lilongwe, Malawi., Khoshnia M; Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran., Malekzadeh R; Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran., Menya D; School of Public Health, Moi University, Eldoret, Kenya., Mmbaga BT; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Center, Moshi, Tanzania.; Kilimanjaro Christian Medical University College, Moshi, Tanzania., Moody S; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Trust Sanger Institute, Cambridgeshire, UK., Mulima G; Kamuzu Central Hospital, Lilongwe, Malawi., Mushi BP; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Mwaiselage J; Ocean Road Cancer Institute, Dar es Salaam, Tanzania., Mwanga A; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Newton Y; NantOmics/NantHealth, Inc., El Segundo, California, USA., Ng DL; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California, USA.; Department of Pathology, UCSF, San Francisco, California, USA., Radenbaugh A; NantOmics/NantHealth, Inc., El Segundo, California, USA., Rwakatema DS; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Center, Moshi, Tanzania.; Kilimanjaro Christian Medical University College, Moshi, Tanzania., Selekwa M; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Schüz J; International Agency for Research on Cancer (IARC/WHO), Environment and Lifestyle Epidemiology Branch, Lyon, France., Taylor PR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Vaske C; NantOmics/NantHealth, Inc., El Segundo, California, USA., Goldstein A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Stratton MR; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Trust Sanger Institute, Cambridgeshire, UK., McCormack V; International Agency for Research on Cancer (IARC/WHO), Environment and Lifestyle Epidemiology Branch, Lyon, France., Brennan P; International Agency for Research on Cancer (IARC), Genomic Epidemiology Branch, Lyon, France., DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Program in Virology, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA., Mmbaga EJ; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.; Department of Community Medicine and Global Health, University of Oslo, Oslo, Norway., Van Loon K; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California, USA.; Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, California, USA.
Source: International journal of cancer [Int J Cancer] 2022 Dec 01; Vol. 151 (11), pp. 1947-1959. Date of Electronic Publication: 2022 Aug 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1097-0215
DOI:10.1002/ijc.34212